An efficient taurine-catalyzed
green multicomponent approach has
been described for the first time to synthesize densely substituted
therapeutic core dihydropyrano[2,3-c]pyrazoles. Applications
of the developed synthetic strategies and technologies revealed the
synthesis of a series of newly designed 1,4-dihydropyrano[2,3-c]pyrazoles containing isonicotinamide, spirooxindole, and
indole moieties. Detailed in silico analysis of the
synthesized analogues revealed their potential to bind wild-type and
antibiotic-resistant variants of dihydrofolate reductase, a principal
drug target enzyme for emerging antibiotic-resistant pathogenic Staphylococcus aureus strains. Hence, the synthesized
dihydropyrano[2,3-c]pyrazole derivatives presented
herein hold immense promise to develop future antistaphylococcal therapeutic
agents.